FINANCIALS

IPHYF Innate Pharma Sa 1598599

Income Statement
Revenue	a6k-iphx250116	12,345,000
Net Income	a6k-iphx250116	-24,764,000
Profit Margin		-200.6%

Balance Sheet
Current Assets	111,594,000
Assets	151,497,000
Current Liabilities	38,224,000
Liabilities	122,701,000
Equity	28,796,000
Shares Out	80,967,000

Cash Flow Statement
Operating Cash Flow	3,036,000
Investing Cash Flow	932,000

Market Analysis
Market Cap	177,421,512
Price	2.90
BVPS	0.36
PB	8.15
PS	14.37
FCF	3,968,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view IPHYF documents filed with the SEC.

IPHYF Filings Clear

View A List of Tickers